Operator of a clinical-stage startup company intended to develop novel drugs for neurodegenerative diseases and diseases of ageing. The company develops nucleoside inhibitors of reverse transcriptase ...

Healthcare
San Diego, CA, United States
Founded 2019
12 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$54.9M
Last Round
N/A

Get the full picture

Create a free account to unlock Transposon's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required